Baird Melissa's Form 4 filing
Hims & Hers Health, Inc. (HIMS) · filed Feb 14, 2025
- Accession no.
- 0001773751-25-000042
- Filed
- Feb 14, 2025, 4:49 PM ET
- Trade date
- Feb 12, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 5 non-derivative transactions and 1 derivative transaction. Open-market sales total $3.03M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Baird MelissaCIK 0001837815 | Officer (Chief Operating Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 12, 2025 | Class A Common Stock | MOption exerciseAcquired | +67,687 | $0.40 | +$27,074.8 | 774,559 | Direct | |
| Feb 12, 2025 | Class A Common Stock | SSaleDisposed | −15,641 | $43.37F2 | −$678,370.5 | 758,918 | Direct | |
| Feb 12, 2025 | Class A Common Stock | SSaleDisposed | −23,172 | $44.35F3 | −$1,027,597.1 | 735,746 | Direct | |
| Feb 12, 2025 | Class A Common Stock | SSaleDisposed | −18,759 | $45.45F4 | −$852,654.7 | 716,987 | Direct | |
| Feb 12, 2025 | Class A Common Stock | SSaleDisposed | −10,115 | $46.27F5 | −$468,001.83 | 706,872 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 12, 2025 | Class A Common Stock | MOption exerciseDisposed | −67,687 | $0.00 | $0 | 122,243 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $42.94 - $43.88. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F3
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $43.955 - $44.68. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F4
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $44.965 - $45.785. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F5
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $45.96 - $46.345. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.